scispace - formally typeset
M

Michael Tuen

Researcher at New York University

Publications -  34
Citations -  845

Michael Tuen is an academic researcher from New York University. The author has contributed to research in topics: Antibody & Epitope. The author has an hindex of 17, co-authored 33 publications receiving 763 citations. Previous affiliations of Michael Tuen include Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Preferential HIV Infection of CCR6+ Th17 Cells Is Associated with Higher Levels of Virus Receptor Expression and Lack of CCR5 Ligands

TL;DR: Results indicate that features unique to Th17 cells, including higher expression of HIV receptors and lack of autocrine CCR5 ligands, are associated with enhanced permissiveness of these cells to HIV.
Journal ArticleDOI

LFA-1 Expression on Target Cells Promotes Human Immunodeficiency Virus Type 1 Infection and Transmission

TL;DR: The presence of wild-type LFA-1 enhanced the initial processes of HIV infection, as well as the subsequent replication and transmission from cell to cell, even though this mutant could help HIV enter cells and establish the initial infection.
Journal ArticleDOI

The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120

TL;DR: Overall this study shows the potential use of gp120/Ab complexes to augment the immunogenicity of HIV-1 envelope gp120, but further improvements are needed to elicit virus-neutralizing Ab responses with higher potency and breadth.
Journal ArticleDOI

HIV-1 N-Glycan Composition Governs a Balance between Dendritic Cell-Mediated Viral Transmission and Antigen Presentation

TL;DR: The results showed that the HIV-1 N-glycan composition plays a crucial role in the balance between DC-mediated Ag degradation and presentation and HIV-mediated virus transmission to target cells.